Coeptis Therapeutics Analyst Ratings
Coeptis Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/13/2022 | 242.86% | EF Hutton | → $6 | Initiates Coverage On | → Buy |
| 12/12/2022 | 242.86% | EF Hutton | → $6 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 12/13/2022 | 242.86% | EF Hutton | → $6 | 開始承保 | →購買 |
| 12/12/2022 | 242.86% | EF Hutton | → $6 | 開始承保 | →購買 |
What is the target price for Coeptis Therapeutics (COEP)?
Coeptis Treeutics(COEP)的目標價格是多少？
The latest price target for Coeptis Therapeutics (NASDAQ: COEP) was reported by EF Hutton on December 13, 2022. The analyst firm set a price target for $6.00 expecting COEP to rise to within 12 months (a possible 242.86% upside). 2 analyst firms have reported ratings in the last year.
Coeptis治療公司(納斯達克：COEP)的最新目標價是由EF Hutton於2022年12月13日報道的。這家分析公司將目標價定為6美元，預計CoEP將在12個月內上漲至242.86(可能上漲242.86)。去年有兩家分析公司公佈了評級。
What is the most recent analyst rating for Coeptis Therapeutics (COEP)?
Coeptis Treeutics(COEP)的最新分析師評級是什麼？
The latest analyst rating for Coeptis Therapeutics (NASDAQ: COEP) was provided by EF Hutton, and Coeptis Therapeutics initiated their buy rating.
科普蒂斯治療公司(納斯達克代碼：COEP)的最新分析師評級由EF Hutton提供，科普蒂斯治療公司啟動了他們的買入評級。
When is the next analyst rating going to be posted or updated for Coeptis Therapeutics (COEP)?
Coeptis Treeutics(COEP)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Coeptis Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Coeptis Therapeutics was filed on December 13, 2022 so you should expect the next rating to be made available sometime around December 13, 2023.
分析師在進行了廣泛的研究後得出股票評級，其中包括查閱公共財務報表，與Coeptis治療公司的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Coeptis治療公司的上一次評級是在2022年12月13日提交的，因此您應該預計下一次評級將在2023年12月13日左右提供。
Is the Analyst Rating Coeptis Therapeutics (COEP) correct?
分析師對Coeptis Treeutics(COEP)的評級正確嗎？
While ratings are subjective and will change, the latest Coeptis Therapeutics (COEP) rating was a initiated with a price target of $0.00 to $6.00. The current price Coeptis Therapeutics (COEP) is trading at is $1.75, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Coeptis治療(COEP)評級是以0.00美元至6.00美元的目標價啟動的。Coeptis Treateutics(CoEP)目前的交易價格為1.75美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。